MIRA Pharmaceuticals Ownership | Who Owns MIRA Pharmaceuticals?


OverviewFinancialsChart

MIRA Pharmaceuticals Ownership Summary


MIRA Pharmaceuticals is owned by 5.82% institutional investors, 19.68% insiders, and 74.50% retail investors. Praetorian wealth management is the largest institutional shareholder, holding 0% of MIRA shares.

MIRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMIRA Pharmaceuticals5.82%19.68%74.50%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryDrug Manufacturers - General Stocks37.59%1.26%61.15%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Praetorian wealth management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Praetorian wealth management---

Top Buyers

HolderShares% AssetsChange
Praetorian wealth management---17.50K

Top Sellers

HolderShares% AssetsChange
Praetorian wealth management---17.50K

Sold Out

HolderChange
Praetorian wealth management-17.50K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202519-17.39%968,472-13.53%511.07%8-57.89%5400.00%
Dec 31, 20242353.33%1,119,95334.88%723.89%19137.50%1-80.00%
Sep 30, 20241536.36%830,30216.63%523.75%860.00%5-
Jun 30, 202411-711,91811.07%445.54%5-50.00%--
Mar 31, 20241183.33%640,949561.87%31195.40%1066.67%--

Recent Insider Transactions


DateNameRoleActivityValue
Nov 20, 2024Aminov Erez Chief Executive OfficerSell$56.63K
Nov 19, 2024Aminov Erez Chief Executive OfficerSell$77.02K
Aug 28, 2024McNulty Brian Patrick-Sell$392.00K
May 21, 2024Aminov Erez Chief Executive OfficerBuy$808.00
May 21, 2024Aminov Erez Chief Executive OfficerBuy$850.00

Insider Transactions Trends


DateBuySell
2024 Q4-2
2024 Q3-1
2024 Q28-
2024 Q1--
2023 Q3--

MIRA Ownership FAQ


Who Owns MIRA Pharmaceuticals?

MIRA Pharmaceuticals shareholders are primarily institutional investors at 5.82%, followed by 19.68% insiders and 74.50% retail investors. The average institutional ownership in MIRA Pharmaceuticals's industry, Drug Manufacturers - General Stocks, is 37.59%, which MIRA Pharmaceuticals falls below.

Does Blackrock own MIRA Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of MIRA Pharmaceuticals.

Who is MIRA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Praetorian wealth management is MIRA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 MIRA Pharmaceuticals shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools